NEW YORK (Reuters Health) – The cumulative incidence of osteonecrosis of the jaw was about 2% over 6 years among women with early breast cancer who received intensive…
NEW YORK (Reuters Health) – Morbidity associated with inguinal lymphadenectomy in patients with penile carcinoma has declined, and is “reasonable” considering the potential benefit, a Brazilian team reports.…
By David Douglas NEW YORK (Reuters Health) – Dual HER2 blockade didn’t increase heart problems in a meta-analysis of data from patients with HER2-positive breast cancer. “The combination…
NEW YORK (Reuters Health) – For patients with head and neck or esophageal cancer undergoing chemoradiotherapy, enteral nutrition enriched with n-3 fatty acids helps preserve body mass. The…
By Will Boggs, MD NEW YORK (Reuters Health) – Hormone therapy may suffice for women with stage IA endometrial cancer of all grades, if they want to try…
This month in Discussions in Diabetes, Steven Edelman, MD, and Robert Henry, MD, discuss how physicians can use incretins to help patients with type 2 diabetes reach their…
NEW YORK (Reuters Health) – A review of the literature indicates that, far from being futile, radical prostatectomy improves outcomes when lymph nodes (LNs) are found to be…
Over the past decade advanced technologies have been introduced to potentially minimize the side effects of conventional prostate cancer treatments. A new study examined the increased use of…
NEW YORK (Reuters Health) – Since the mid-90s, early survival rates after allogeneic hematopoietic cell transplantation (alloHCT) among patients with hematologic diseases have improved significantly, based on an…
By Robert Saunders NEW YORK (Reuters Health) – For men with biochemical recurrence of prostate cancer after radical prostatectomy, radiation offers a good chance of cure, according to…
Last fall, a multi-state outbreak of fungal meningitis occurred after contaminated steroid injections were given to patients to treat back pain and other neuropathic symptoms. These contaminated injections…
Herbert Lepor, MD, and Danil Makarov, MD, MHS discuss treating lower urinary track symptoms (LUTS). They explain why one of the treatments, 5-ARIs, are no longer approved for chemoprevention by…
